Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Schoepke

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Indian Journal of Dermatology|June 1, 2013
Diagnosis of urticariaNicole Schoepke, Georgios Doumoulakis, Marcus Maurer
Acta Dermato-Venereologica|November 14, 2012
The inhibition by levocetirizine and fexofenadine of the histamine-induced wheal and flare response in healthy Caucasian and Japanese volunteersNicole Schoepke, Martin K Church, Marcus Maurer
The World Allergy Organization Journal|December 27, 2012
Effects of a Novel GA(2)LEN Training Program on Urticaria on the Knowledge of General Practitioners in Saudi-ArabiaMarcus Maurer, Carsten Bindslev-Jensen, Nicole Schoepke, et al.
Immunology and Allergy Clinics of North America|November 26, 2016
Clinical Measures of Chronic UrticariaKarsten Weller, Frank Siebenhaar, Tomasz Hawro, et al.
Immunology and Allergy Clinics of North America|November 23, 2013
Physical urticarias and cholinergic urticariaMarina Abajian, Nicole Schoepke, Sabine Altrichter, et al.
Acta Dermato-Venereologica|August 31, 2017
Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical AprepitantTatevik Ohanyan, Nicole Schoepke, Stefan Eirefelt, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 13, 2017
The Urticaria Activity Score-Validity, Reliability, and ResponsivenessTomasz Hawro, Tatevik Ohanyan, Nicole Schoepke, et al.
Acta Dermato-Venereologica|November 4, 2015
Anti-pruritic Effect of Sertaconazole 2% Cream in Atopic Dermatitis Subjects: A Prospective, Randomized, Double-blind, Vehicle-controlled, Multi-centre Clinical Trial of Efficacy, Safety and Local TolerabilitySonja Ständer, Martin Metz, Mac H Ramos F, et al.
The Journal of Allergy and Clinical Immunology|April 9, 2017
Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trialMarcus Maurer, Andrea Schütz, Karsten Weller, et al.
Clinical and Translational Allergy|January 31, 2025
Development of the symptomatic dermographism quality of life questionnaireMelba Muñoz, Nicole Schoepke, Sabine Altrichter, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Indian Journal of Dermatology|June 1, 2013
Diagnosis of urticariaNicole Schoepke, Georgios Doumoulakis, Marcus Maurer
Acta Dermato-Venereologica|November 14, 2012
The inhibition by levocetirizine and fexofenadine of the histamine-induced wheal and flare response in healthy Caucasian and Japanese volunteersNicole Schoepke, Martin K Church, Marcus Maurer
The World Allergy Organization Journal|December 27, 2012
Effects of a Novel GA(2)LEN Training Program on Urticaria on the Knowledge of General Practitioners in Saudi-ArabiaMarcus Maurer, Carsten Bindslev-Jensen, Nicole Schoepke, et al.
Immunology and Allergy Clinics of North America|November 26, 2016
Clinical Measures of Chronic UrticariaKarsten Weller, Frank Siebenhaar, Tomasz Hawro, et al.
Immunology and Allergy Clinics of North America|November 23, 2013
Physical urticarias and cholinergic urticariaMarina Abajian, Nicole Schoepke, Sabine Altrichter, et al.
Acta Dermato-Venereologica|August 31, 2017
Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical AprepitantTatevik Ohanyan, Nicole Schoepke, Stefan Eirefelt, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 13, 2017
The Urticaria Activity Score-Validity, Reliability, and ResponsivenessTomasz Hawro, Tatevik Ohanyan, Nicole Schoepke, et al.
Acta Dermato-Venereologica|November 4, 2015
Anti-pruritic Effect of Sertaconazole 2% Cream in Atopic Dermatitis Subjects: A Prospective, Randomized, Double-blind, Vehicle-controlled, Multi-centre Clinical Trial of Efficacy, Safety and Local TolerabilitySonja Ständer, Martin Metz, Mac H Ramos F, et al.
The Journal of Allergy and Clinical Immunology|April 9, 2017
Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trialMarcus Maurer, Andrea Schütz, Karsten Weller, et al.
Clinical and Translational Allergy|January 31, 2025
Development of the symptomatic dermographism quality of life questionnaireMelba Muñoz, Nicole Schoepke, Sabine Altrichter, et al.
Pageof 2